A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention
- Status
- TERMINATED
- Phase
- PHASE3
Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study of Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer Treated With Herceptin (Trastuzumab) in 1st Line and Without Progression For 3 Years
- Status
- COMPLETED
- Phase
- N/A
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2